Use of the HoloLens2 Mixed Reality Headset for Protecting Health Care Workers During the COVID-19 Pandemic: Prospective, Observational EvaluationOriginal Paper Published on 2020-08-142022-10-30 Journal: Journal of Medical Internet Research [Category] COVID-19, MERS, [키워드] acceptability addressed assessment augmented reality Care clinical care Cluster Cohort collected conducted coronavirus disease COVID-19 COVID-19 pandemic COVID-19 patient Effectiveness evaluated Evidence feasibility Headset hospital Impact IMPROVE infection control information majority mixed reality New Nosocomial infection objective pandemic Personal protective equipment pilot PPE Prospective PROTECT Protecting protection REALITY reduced reduction in Result Support supported Telemedicine United Kingdom virtual reality worker [DOI] 10.2196/21486 PMC 바로가기 [Article Type] Original Paper
An Integrated Strategy for the Prevention of SARS-CoV-2 Infection in Healthcare Workers: A Prospective Observational StudyArticle Published on 2020-08-102022-10-29 Journal: International Journal of Environmental Research an [Category] COVID-19, MERS, [키워드] adopted advance asymptomatic infection body temperature Clinical data collected composed conducted demographic Efficiency evaluated HCW HCWs health care workers healthcare personnel healthcare worker hospital implementation infected patient infected patients Infection infection control involved Italy management measure Nasopharyngeal swab Novel coronavirus Occurrence outbreak Patient performed Personal protective equipment positive PPE Prevent prevention primary endpoint Prospective prospective observational study reached recorded reported respiratory protective device SARS-CoV-2 SARS-COV-2 infection secondary endpoint Strategy Surveillance Swab Symptom symptomatic symptomatic infection tested Transmission Triage university [DOI] 10.3390/ijerph17165785 PMC 바로가기 [Article Type] Article
Nigella sativa supplementation to treat symptomatic mild COVID-19: A structured summary of a protocol for a randomised, controlled, clinical trialLetter Published on 2020-08-082022-10-29 Journal: Trials [Category] COVID-19, MERS, [키워드] 1:1 absence Admission Alanine transaminase assigned Black seed Blinding block Breast feeding Chronic kidney disease chronic liver disease clinical trial clinically comparator computer-generated randomization conducted control group control groups COVID-19 COVID19 Date defined dialysis disease dissemination Efficacy element eligible patient exploratory glomerular filtration rate hospital Infection intensive care Jeddah King limit medication Mild Nigella Sativa no symptoms number objective Open-label outcome parallel-group participant Patient phytotherapy Pneumonia polymerase chain reaction Prospective protocol radiological randomisation randomised randomised controlled trial Randomly recruited renal respiratory Sample size SARS-CoV-2 Saudi Arabia Standard of care status Symptom symptomatic mild the patient throat swab transfer treat Treatment Trial Two-arm university upper respiratory tract website written Informed Consent [DOI] 10.1186/s13063-020-04647-x PMC 바로가기 [Article Type] Letter
Safety and COVID-19 Symptoms in Individuals Recently Vaccinated with BCG: a Retrospective Cohort StudyArticle Published on 2020-08-052022-10-04 Journal: Cell Reports Medicine [Category] MERS, 유전자 메커니즘, [키워드] adjusted odds ratio Bacille Calmette-Guérin bacille Calmette-Guérin BCG BCG vaccination Cohort coronavirus disease COVID-19 COVID-19 outbreak COVID-19 pandemic decrease disease symptom Effectiveness extreme fatigue healthy volunteer hyperinflammation Immunity incidence individual induce innate immune responses Innate immunity Netherlands non-specific effects off-target effects prevention of COVID-19 Prospective raised randomized clinical trial randomized trial recent reduce reduced reducing Respiratory tract infections retrospective cohort study Safe Safety SARS-CoV-2 SARS-COV-2 infection severity Sickness susceptibility Symptom trained immunity Trial [DOI] 10.1016/j.xcrm.2020.100073 PMC 바로가기 [Article Type] Article
Reprocessing filtering facepiece respirators in primary care using medical autoclave: prospective, bench-to-bedside, single-centre studyGeneral practice / Family practice Published on 2020-08-042022-10-28 Journal: BMJ Open [Category] COVID-19, Fulltext, MERS, [키워드] Aura baseline breathing change COVID-19 pandemic exhalation valve Healthcare professional indicated Laboratory Mask objective Particle penetration Personal protective equipment primary care Prospective public health Respirator respiratory infections Result retained Safe selected setting tested were used widespread worker [DOI] 10.1136/bmjopen-2020-039454 PMC 바로가기 [Article Type] General practice / Family practice
Fat mass affects nutritional status of ICU COVID-19 patientsResearch Published on 2020-08-032022-10-30 Journal: Journal of Translational Medicine [Category] COVID-19, MERS, [키워드] addition adipose Admission Affect affected age analyzed BMI body mass index characteristic COVID-19 COVID-19 patient disease evaluate Fat mass hepatic function ICU ICU Patients immune response Inflammation intensive care unit mass nutritional status obese obesity organ outcome Patient patients percentage Pneumonia PNI pro-inflammatory cytokine Prognosis prognostic Prospective reduced Result severe pneumonia steatosis survival tissue with COVID-19 [DOI] 10.1186/s12967-020-02464-z PMC 바로가기 [Article Type] Research
Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19Research article Published on 2020-08-012022-10-05 Journal: International Journal of Infectious Diseases [Category] SARS, 치료법, [키워드] Admission Admissions African American age CKD Combination coronavirus COVID-19 COVID-19 pandemic Cox regression Detroit effective effective therapy evaluate expired exposure Follow-up hazard ratio Health health system Henry Ford highlighting hospital Hospitalization hospitalized patient Hydroxychloroquine hydroxychloroquine therapy in-hospital mortality Inpatient male median median age median time Mortality O2 Saturation objective Older outcome participant Patient patients patients evaluated patients hospitalized positive predictor Primary outcome Prospective provided receipt reduced reduction reduction in Respiratory failure Result retrospective Risk factors SARS-CoV-2 setting Significance System Therapies therapy torsades de pointes treated Treatment Trial United State urgency Vaccine ventilator with COVID-19 [DOI] 10.1016/j.ijid.2020.06.099 [Article Type] Research article
Therapeutic Anticoagulation Delays Death in COVID-19 Patients: Cross-Sectional Analysis of a Prospective CohortOriginal Article Published on 2020-07-262022-10-29 Journal: TH Open: Companion Journal to Thrombosis and Haemostasis [Category] COVID-19, [키워드] 95% confidence interval Analysis anticoagulation benefit coronavirus disease COVID-19 COVID-19 patient COVID-19 patients cross-sectional analysis death death in COVID-19 Deceased Delay described dose dose-dependent manner hazard ratio heparin hypercoagulable limitation Novel coronavirus Other Patient patients performed Prophylactic Prospective reported required retrospective survival therapeutic anticoagulation therapeutic dose Trial [DOI] 10.1055/s-0040-1716721 PMC 바로가기 [Article Type] Original Article
A systematic review of neurological symptoms and complications of COVID-19Review Published on 2020-07-202022-10-29 Journal: Journal of Neurology [Category] COVID-19, MERS, [키워드] Analysis applied article articles association cerebrospinal fluid Chinese cohort study Complication complications of COVID-19 Course COVID-19 COVID-19 patient Critical disease database described Dizziness events Frequency identify Immune-mediated infection with SARS-CoV-2 International multiple sclerosis nervous system neuro-COVID Neurological disease Neurological diseases neurological manifestation neurological manifestations Neurological symptom Neurological symptoms non-specific objective Parkinson’s disease Patient Prospective protocol Quantitative analysis Registered reported Result retrieved review SARS-CoV-2 SARS-COV-2 infection screened searched Seizures supplementary material systematic review with COVID-19 [DOI] 10.1007/s00415-020-10067-3 PMC 바로가기 [Article Type] Review
No Statistically Apparent Difference in Antiviral Effectiveness Observed Among Ribavirin Plus Interferon-Alpha, Lopinavir/Ritonavir Plus Interferon-Alpha, and Ribavirin Plus Lopinavir/Ritonavir Plus Interferon-Alpha in Patients With Mild to Moderate Coronavirus Disease 2019: Results of a Randomized, Open-Labeled Prospective StudyPharmacology Published on 2020-07-142022-10-31 Journal: Frontiers in Pharmacology [Category] COVID-19, [키워드] acute respiratory syndrome adverse event adverse events Analysis Antiviral antiviral therapy Antiviral treatment baseline calculated clinical clinical trial Combination comparable conducted coronavirus coronavirus disease COVID-19 COVID-19 patient difference Effectiveness effectiveness and safety enrolled Follow-up group IFN-α incidence include intention-to-treat interferon-alpha Interferon-α laboratory characteristics Lopinavir/ritonavir median interval Mild Mild to moderate COVID-19 Moderate COVID-19 Mortality negativity no significant difference nucleic acid Observed outcome pandemic Patient patients with SARS-CoV-2 proportion Prospective Prospective clinical trial Randomized regimen Registration Result ribavirin SARS-CoV-2 SARS-CoV-2 nucleic acid severe cases significant increase significantly higher single-center Spread statistically study period the median three groups [DOI] 10.3389/fphar.2020.01071 PMC 바로가기 [Article Type] Pharmacology